NCT04242238View on ClinicalTrials.gov

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 22, 2020

Primary Completion Date

August 26, 2025

Study Completion Date

August 26, 2025

Conditions
SarcomaAdvanced SarcomaHigh Grade SarcomaLeiomyosarcomaUndifferentiated Pleomorphic SarcomaMyxofibrosarcomaDedifferentiated Liposarcoma
Interventions
DRUG

DCC-3014

DCC-3014 will be administered in pill form. Start Day 1 on first cycle and continue with dosing of DCC-3014.

DRUG

Avelumab

Start Day 1 on first cycle with further infusions of avelumab every 14 days

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

ENABLE MEDICINE
All Listed Sponsors
collaborator

ENABLE MEDICINE

UNKNOWN

lead

Memorial Sloan Kettering Cancer Center

OTHER